offer
all report title image
  • Published On : Oct 2022
  • Code : CMI1011
  • Industry : Pharmaceutical
  • Pages : 178
  • Formats :

The placenta secretes human chorionic gonadotropin hormone (HCG), a hormone, after the implantation of a fertilized zygote in the uterus .HCG plays a major role in stimulating the egg release from the ovary and promotes normal development of the egg. In infertility treatment, the HCG induces ovulation in the women and increases the sperm count in males. A substance called human chorionic gonadotropin (HCG) is produced by trophoblast tissue, which is normally present in early embryos.

Global human chorionic gonadotropin (HCG) market is estimated to be valued at US$ 710.88 Million in 2022 and is expected to exhibit a CAGR of 6.5% during the forecast period (2022-2030).

Figure 1. Global Human Chorionic Gonadotropin Market (HCG) Share (%), by Product Type, 2022

Human Chorionic Gonadotropin (HCG)  | Coherent Market Insights

Increasing infertility rates globally are expected to augment growth of the global human chorionic gonadotropin (HCG) market over the forecast period.

Increasing infertility rates globally are expected to augment growth of the global human chorionic gonadotropin (HCG) market over the forecast period. For instance, according to the report published in Galadari Printing and Publishing LLC, 2018, the prevalence of infertility increased with a significant decline in demographics ranging from 6.6 births per woman in the 1970s to 5.22 children in 1980-1985 and 1.73 from 2015- 2020, registering an overall decrease of 160%.

Figure 2. Global Human Chorionic Gonadotropin Market (HCG) Share (%), by Distribution Channel, 2022

Human Chorionic Gonadotropin (HCG)  | Coherent Market Insights

Increase in incidence of hypogonadism-related disorders is expected to drive the market growth during the forecast period.

Increase in incidence of hypogonadism-related disorders is expected to drive the market growth during the forecast period. For instance, according to the Endocrine Society (January 2022), globally hypogonadism is a common condition in the male population, with a higher prevalence in older men, obese men, and men with type 2 diabetes.

CMI table icon

Human Chorionic Gonadotropin (HCG) Market Report Coverage

Report Coverage Details
Base Year: 2021 Market Size in 2022: US$ 710.88 Mn
Historical Data for: 2017 to 2020 Forecast Period: 2022 to 2030
Forecast Period 2022 to 2030 CAGR: 6.5% 2030 Value Projection: US$ 1,176.22 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Product Type: Human Chorionic Gonadotropin, Recombinant Human Chorionic Gonadotropin
  • By Therapeutics Application: Male Hypogonadism, Female Infertility Treatment, Oligospermic Treatment, Cryptorchidism Treatment, Chronic Pain, Others
  • By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Companies covered:

Merck & Co., Inc., Ferring B.V.,Fresenius SE & Co.KGaA,Lupin,Sun Pharmaceutical Industries Ltd,Lee BioSolutions,Serum Institute of India Pvt. Ltd., Scripps Laboratories,Sanzyme Biologics Pvt. Ltd.,VHB Medi Sciences Limited, Bharat Serums And Vaccines Limited (BSV), Zydus Lifesciences Ltd, Corona Remedies Pvt. Ltd.

Growth Drivers:
  • Increasing rate of infertility
  • Increase in incidence of hypogonadism-related disorders
Restraints & Challenges:
  • Side effects associated with human chorionic gonadotropin (HCG)

Global Human Chorionic Gonadotropin (HCG) Market – Impact of Coronavirus (COVID-19) Pandemic

The lockdown or shutdown has impacted the healthcare industry. The COVID-19 has negatively hampered and disrupted the overall healthcare facilities. Supply chain and manufacturing activities in India, Italy, Spain, the U.K., and the U.S. have been disrupted due to lockdowns implemented by governments. while countries such as Saudi Arabia, the U.A.E, Egypt, and others are facing problems with regard to the transportation of raw materials, chemicals, and finished products. The coronavirus or COVID-19 outbreak that started from Wuhan, China has spread across continents, affecting various industries globally .The supply of key materials has been severely disrupted due to forced quarantine and lack of labor. As the link between regional warehouses is not smooth, the transportation of raw material required for development of product between regions cannot be carried out successfully.

Global Human Chorionic Gonadotropin (HCG) Market: Restraint

The major factors that may hinder growth of the global human chorionic gonadotropin (HCG) market include side effects associated with human chorionic gonadotropin (HCG). The side effects associated with human chorionic gonadotropin (HCG) include chest pain, rapid weight gain, trouble in breathing, severe nausea, vomiting, decreased urination, pain or swelling in one leg, or sudden numbness on one side of the body. Furthermore, easy availability of alternatives to treat infertility could act as potential barriers for the market growth.

Key Players                                                

Major players operating in the global human chorionic gonadotropin (HCG) market include Merck & Co., Inc., Ferring B.V.,Fresenius SE & Co.KGaA, Lupin, Sun Pharmaceutical Industries Ltd,Lee BioSolutions,Serum Institute of India Pvt. Ltd., Scripps Laboratories,Sanzyme Biologics Pvt. Ltd.,VHB Medi Sciences Limited Bharat Serums And Vaccines Limited (BSV), Zydus Lifesciences Ltd, Corona Remedies Pvt. Ltd.

Human chorionic gonadotropin (HCG) is a hormone secreted by the placenta after implantation of a fertilized zygote in the uterus. The hormone also supports normal development of an egg and helps in the stimulation of egg release from the ovary. HCG is mainly used to induce ovulation in the women under infertility treatment. It is also used among males, mostly to increase the sperm count and in young boys due to pituitary gland disorders and other diseases, owing to which the testicles of the young males do not drop down naturally into the scrotum. The HCG is usually administered as an injection under the skin into a muscle. The HCG can also be administered at home under the advice of a gynecologist or a pharmacist. The HCG levels can be determined with the help of urine or blood test. Result of specific test helps in determining accurate measurement of the levels. These tests are mostly used to identify and confirm pregnancy or as a screening test to determine birth defects. The hormone stimulates the corpus luteum to produce progesterone to maintain the pregnancy.

Market Dynamics

The increasing adoption of inorganic strategies such as partnerships and acquisitions by the key players in the market is expected to drive the market growth over the forecast period. For instance, in January 2021, Merck & Co., Inc., a science and technology company announced a multi-year partnership with Royal Philips, which is a health technology company, to develop clinical-grade digital solutions for highly personalized fertility treatment.

Key features of the study:

  • This report provides an in-depth analysis of the global human chorionic gonadotropin (HCG) market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global human chorionic gonadotropin (HCG) market based on the following parameters – Company Highlights, Products Portfolio, Key Highlights, Financial Performance, Strategies.
  • Key companies covered as a part of this study includes Merck & Co., Inc., Ferring B.V., Fresenius SE & Co.KGaA, Lupin, Sun Pharmaceutical Industries Ltd, Lee BioSolutions, Serum Institute of India Pvt. Ltd., Scripps Laboratories, Sanzyme Biologics Pvt. Ltd., VHB Medi Sciences Limited, Bharat Serums And Vaccines Limited (BSV), Zydus Lifesciences Ltd, Corona Remedies Pvt. Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global human chorionic gonadotropin (HCG) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global human chorionic gonadotropin hormone (HCG) market.

Detailed Segmentation:

  • Global Human chorionic gonadotropin hormone (HCG) Market, By Product Type:
    • Human Chorionic Gonadotropin
    • Recombinant Human Chorionic Gonadotropin
  • Global Human chorionic gonadotropin hormone (HCG) Market,, By Therapeutic Application:
    • Male Hypogonadism
    • Female Infertility Treatment
    • Oligospermic Treatment
    • Cryptorchidism Treatment
    • Chronic Pain
    • Others
  • Global Human chorionic gonadotropin hormone (HCG) Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Human chorionic gonadotropin hormone (HCG) Market, By Region:
    • North America
      • By Country
        • U.S.
        • Canada
    • Latin America
      • By Country
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Country
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Country
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Country
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Country
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Merck & Co., Inc.,*
      • Company Highlights
      • Products Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Ferring B.V.,
    • Fresenius SE & Co.KGaA
    • Lupin
    • Sun Pharmaceutical Industries Ltd
    • Lee BioSolutions
    • Serum Institute of India Pvt. Ltd.,
    • Scripps Laboratories
    • Sanzyme Biologics Pvt.
    • VHB Medi Sciences Limited
    • Bharat Serums And Vaccines Limited (BSV)
    • Zydus Lifesciences Ltd
    • Corona Remedies Pvt. Ltd.

“*” marked represents similar segmentation in other categories in the respective section.

Frequently Asked Questions

Global human chorionic gonadotropin (HCG) market size is estimated to be valued at US$ 710.88 million in 2022 and is expected to exhibit a CAGR of 6.5% between 2022 and 2030.
Factors such as increasing rate of infertility and increase in incidence of hypogonadism-related disorders are expected to drive the market growth over the forecast period.
Female Infertility Treatment segment is expected to hold a major market share during the forecast period.
The major factors that may hinder growth of the market include side effects associated with human chorionic gonadotropin (HCG). The side effects associated with human chorionic gonadotropin (HCG) include chest pain, rapid weight gain, trouble in breathing, severe nausea, vomiting, decreased urination, pain or swelling in one leg, or sudden numbness on one side of the body. Furthermore, easy availability of alternatives to treat infertility could act as potential barriers for the market growth.
Major players operating in the market include Merck & Co., Inc., Ferring B.V.,Fresenius SE & Co.KGaA,Lupin,Sun Pharmaceutical Industries Ltd,Lee BioSolutions,Serum Institute of India Pvt. Ltd., Scripps Laboratories,Sanzyme Biologics Pvt. Ltd.,VHB Medi Sciences Limited Bharat Serums And Vaccines Limited (BSV), Zydus Lifesciences Ltd, Corona Remedies Pvt. Ltd.

Related Reports

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo